🔎 Trials Near Me

Akèy › Kansè Metastatik › Florid › Orlando

Etid klinik pou Kansè Metastatik nan Orlando, FL

29 etid pou Kansè Metastatik ap chèche patisipan nan sit nan ak bò kote Orlando (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Ap rekriteFaz 1/2
  • Advent Health, Orlando
Laj 12 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04585750

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Ap rekriteFaz 1
  • AdventHealth Cancer Institute, Orlando
Laj 19 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06586957

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

Ap rekriteFaz 2/3
  • AdventHealth Orlando, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06943755

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Ap rekriteFaz 1
  • Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07277413

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Ap rekriteFaz 3
  • Florida Cancer Specialists, Orlando
  • Orlando Health Ambulatory Care Center, Orlando
  • Orlando Health Cancer Institute, Orlando
  • ak 4 plis
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07222566

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Ap rekriteFaz 3
  • AdventHealth Orlando, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07218380

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Ap rekriteFaz 3
  • AdventHealth Altamonte Springs, Altamonte Springs · 9 mi lwen
  • Clermont Oncology Center, Clermont · 24 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07174336

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Ap rekriteFaz 3
  • AdventHealth Orlando, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07213804

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Ap rekriteFaz 1/2
  • Orlando Health Ambulatory Care Center, Orlando
  • Orlando Health Cancer Institute, Orlando
  • Orlando Health Orlando Regional Medical Center, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07227415

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1/2
  • Clinical Study Site, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT07335497

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Ap rekriteFaz 3
  • Orlando Health Cancer Institute, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06119581

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Ap rekriteFaz 1/2
  • Avenzo Therapeutics Recruiting Site, Orlando
Laj 18 a 75 · Tout sèks · Mizajou Sep 4, 2026 · NCT07038343

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

Ap rekriteFaz 1
  • Sarah Cannon Research Institute - Florida Cancer Specialists, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT04913285

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Ap rekriteFaz 3
  • Advent Health - Orlando, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06072612

BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

Ap rekriteFaz 1/2
  • Avenzo Therapeutics Recruiting Site, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT07193511

A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1
  • Adventhealth, Celebration · 17 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT06803680

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Ap rekriteFaz 1
  • Advent Health, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT05614739

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Ap rekriteFaz 3
  • Research Site, Orlando
Laj 18 ak plis · Fanm · Mizajou Jul 29, 2026 · NCT07044336

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • Orlando Health UF Health Cancer Center, Orlando
Laj 12 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT05533697

A Study of LY4175408 in Participants With Advanced Cancer

Ap rekriteFaz 1
  • Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Jun 23, 2026 · NCT07046923

(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors

Ap rekriteFaz 3
  • Orlando Health Cancer Institute, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Jun 16, 2026 · NCT05208047

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Ap rekriteFaz 1
  • Research Site, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Jun 10, 2026 · NCT06835569

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

Ap rekriteFaz 3
  • AdventHealth Medical Group Oncology & Hematology at Orlando, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Apr 9, 2026 · NCT06064877

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

Ap rekriteFaz 1/2
  • Florida Cancer Specialists, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Apr 1, 2026 · NCT05735080

A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1
  • AdventHealth Cancer Institute, Celebration · 17 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Mar 20, 2026 · NCT05948865

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1/2
  • Florida Cancer Specialists-Lake Nona, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Feb 18, 2026 · NCT07030257

JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors

Ap rekriteFaz 1
  • Florida Cancer Specialists, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Dec 16, 2025 · NCT06108050

Etid Kansè Metastatik nan lòt vil

Lòt etid nan Orlando

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.